Clinical Trials on Anticoagulation in France

Total 11 results

Bayer
Janssen Research & Development, LLC; RTI Health Solutions

Completed

Patient and Physician Knowledge of Key Safety Messages

Anticoagulation

Germany, United Kingdom, France, Spain
University Hospital, Montpellier

Completed

Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education (EDUCONSULT)

Under Oral Anticoagulation Patients

France
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE) (TRACE)

Anticoagulation | Left Ventricular Assist Device

United States, Austria, France, Germany, Czechia
SANE-Society of Anesthesiology
Instituto de Cardiologia do Rio Grande do Sul; Fundação Universitária de Cardiologia...

Completed

Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass

Cardiac Surgery | Cardiopulmonary Bypass | Anticoagulation

Brazil
Nantes University Hospital

Recruiting

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels (UniXa)

Atrial Fibrillation | Venous Thromboembolism | Anticoagulation

France
Bristol-Myers Squibb

Completed

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Anticoagulation

France
Bristol-Myers Squibb

Completed

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Anticoagulation

France
Assistance Publique - Hôpitaux de Paris

Completed

Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid (INWARA)

Atrial Fibrillation | Pulmonary Embolism | Deep Venous Thrombosis | Oral Anticoagulation

France
Centre Hospitalier Universitaire Dijon

Recruiting

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study (API-AHAI)

Autoimmune Hemolytic Anemia | Venous Thromboembolic Disease | Prolonged Anticoagulation

France
Insel Gruppe AG, University Hospital Bern
Sahajanand Medical Technologies Limited

Recruiting

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation (MATRIX-2)

Atrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 Inhibitor

Spain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
University Hospital, Angers

Completed

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation (VICTORIA)

Venous Thrombosis | Pulmonary Embolism | Permanent Atrial Fibrillation | Anticoagulation Treatment at Least > or = to 12-month

France

Clinical Trials on Anticoagulation in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations